Corporate Updates

Metropolis develops screening test to predict genetic predisposition to baldness

eHEALTH BureauMetropolis Healthcare Ltd, India’s only multi-national chain of diagnostics centre, has developed a screening test to predict whether an individual is genetically predisposed to hereditary male and female pattern baldness.After exhaustive research, the Molecular Biology department of Metropolis has developed the Genetic Test for Hair Loss that provides an accurate genetic analysis of a man or woman’s likelihood of developing Andogenetic Alopecia, the most common type of hair loss.The test involves DNA analysis and determines whether an individual has inherited the receptor gene of ‘androgenetic alopecia’. The genetic screening test for the pattern of hair loss helps the doctor assess the risk involved and can provide one with an early medical intervention prior to visible signs of the same. The genetic test costs Rs 9,000 and is most appropriate for people above 18 years of age who are concerned about hair loss or for those who have a family history of baldness.Says Ameera Patel, Metropolis Healthcare Ltd CEO and utive Director, “Early detection or prediction of hair loss can help in recommending the most effective medication to prevent future hair loss and baldness. The genetic test for hair loss will help an individual determine a genetic susceptibility to hair loss before thinning or receding hair becomes apparent.”

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Most Popular

To Top